Member Info for Benharper

2% down on low volume, ‘dropping like a stone’. Do you live on the moon?

Blocked me too, I use twitter but don’t have many followers as I use it to just follow a couple of subjects, so I guess it’s easy to look like one of the infamous trolls, unblock me and I’ll happily vote RAH

RAH, okay, I was only playing out the serious worst case given we’ve seen a 3 week lead in to recruitment on some of the recent recruitment forms. I’m still hopeful for soon , tomorrow even. But I’m happily holding and waiting with no ‘concerns’

I had a similar though re timelines RAH but added 3 weeks for recruitment which takes us to the end of Jan. Obviously worse/longest wait scenario

If that’s what you think Terry it’s an obvious short target, go for it I dare you..

I genuinely checked to see if it was full moon. Might have explained your occasional angry outbursts.

Sounds genuine enough to me, but it’s the kind of stock answer a tired dr who had heard fleetingly of Ava6000 would give. We can’t expect everyone to be as up to date and onboard as us ‘waiting with baited breathe’ shareholders.

Times and Sky are probably the same article more or less, all Murdoch

Yep Touk, I hope they get the packaging and marketing right too, perhaps a catchy add on itv. Twat

Mr A, Matt Vincent from Point could be a relevant ex employee. Obviously just my wild stab in the dark..

Even a stopped clock tells the right time twice a day

Is it to obvious to suggest a lump just under the skin would be fairly straight forward to biopsy? So activation in the Tme has been confirmed in this cancer types case . It could be a contributing factor to its selection at the very least..

I’d agree with what you’ve said sorcerer, I’d just add that if each cohort goes to the maximum life time dose of doxorubicin as the dose escalates the length of time each cohort takes to reach the lifetime dose of doxorubicin also decreases. I think there can only be 3 cycles of this DE cohort before this level is met. So we’re looking at 6-9 weeks plus some data collation time until the readout. All barring any hold ups..

So am I right In thinking 50k shares,? So not a huge number but still significant from the expected suitor to Ava3996

Has anyone else noticed in the more recent updates the mention of dose escalation has be sparse to none existent but there is still frequent mention of 3-4 cohorts? Could they be happy with the present dose and have started a third and even forth cohort at this dose and not be reaching a maximum tolerated dose. This theory at least makes sense of the timelines and communication from Avacta.

I can see where this is going Bella. Is he going to buy a house in London on the next spike?

Are the shorters selling into to attempt to drop the price for a big buy or two?

Touk, who are the competitors in clinical trials with a new fap activated 40 years used chemotherapy? I’d love to check them out, might invest in them too

Standard dose of doxorubicin is 90. Avacta dosed first cohort at 80 so increase is 50% but 120 dose escalation is going to be 33% more doxorubicin in the patient than a standard doxorubicin treatment.

I’ve only got one account old boy, and only the need for one as I’m not some kind of weird Machiavellian character getting his only endorphin hit in life from multiple character posting on an investors bulletin board. I don’t normally get involved, but I was just amused at your flip up. Gallows humour eh, you taking coolfree, g-man and all your other split personality alter egos with you? I’ve always been strongly against capital punishment but I’d imagine you’d get a good turn out